Emerging information on the use of rituximab in chronic lymphocytic leukemia

被引：51

作者：

Keating, MJ ^{[1
]}

O'Brien, S ^{[1
]}

Albitar, M ^{[1
]}

机构：

[1] Univ Texas, MD Anderson Canc Ctr, Leukemia Dept, Houston, TX 77030 USA

来源：

SEMINARS IN ONCOLOGY | 2002年 / 29卷 / 01期

关键词：

D O I：

10.1053/sonc.2002.30142

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 [肿瘤学];

摘要：

引用

页码：70 / 74

页数：5

共 15 条

[1]

Rituximab using a thrice weekly dosing schedule in B-Cell chronic lymphocytic leukemia and small lymphocytic lymphoma demonstrates clinical activity and acceptable toxicity [J].

Byrd, JC ;

Murphy, T ;

Howard, RS ;

Lucas, MS ;

Goodrich, A ;

Park, K ;

Pearson, M ;

Waselenko, JK ;

Ling, G ;

Grever, MR ;

Grillo-Lopez, AJ ;

Rosenberg, J ;

Kunkel, L ;

Flinn, IW .

JOURNAL OF CLINICAL ONCOLOGY, 2001, 19 (08) :2153-2164

[2]

BYRD JC, 2001, P AN M AM SOC CLIN, V20, pA280

[3]

National Cancer Institute-sponsored Working Group guidelines for chronic lymphocytic leukemia: Revised guidelines for diagnosis and treatment [J].

Cheson, BD ;

Bennett, JM ;

Grever, M ;

Kay, N ;

Keating, MJ ;

OBrien, S ;

Rai, KR .

BLOOD, 1996, 87 (12) :4990-4997

[4]

Chimeric anti-CD20 (IDEC-C2B8) monoclonal antibody sensitizes a B cell lymphoma cell line to cell killing by cytotoxic drugs [J].

Demidem, A ;

Lam, T ;

Alas, S ;

Hariharan, K ;

Hanna, N ;

Bonavida, B .

CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS, 1997, 12 (03) :177-186

[5]

GARCIAMANERO G, 2000, P AM SOC HEMATOL, V96, pA757

[6]

GOLAY J, 2000, P AM SOC HEMATOL, V96, P1466

[7]

HUH YO, 2000, P AM SOC HEMATOL, V96, pA371

[8]

KATING MJ, 2000, P AM SOC HEMATOL, V96, pA514

[9]

MANSHOURI T, 2000, P AM SOC HEMATOL, V96, pA369

[10]

Rituximab chimeric Anti-CD20 monoclonal antibody therapy for relapsed indolent lymphoma:: Half of patients respond to a four-dose treatment program [J].

McLaughlin, P ;

Grillo-López, AJ ;

Link, BK ;

Levy, R ;

Czuczman, MS ;

Williams, ME ;

Heyman, MR ;

Bence-Bruckler, I ;

White, CA ;

Cabanillas, F ;

Jain, V ;

Ho, AD ;

Lister, J ;

Wey, K ;

Shen, D ;

Dallaire, BK .

JOURNAL OF CLINICAL ONCOLOGY, 1998, 16 (08) :2825-2833

← 1 2 →